Cargando…
Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991068/ http://dx.doi.org/10.1186/2051-1426-1-S1-P213 |
| _version_ | 1782312376086822912 |
|---|---|
| author | Goh, J Mason, J Chan, J Moradi, M Berek, J Beningno, B Mileshkin, L Recio, F Tchabo, N Rossi, E Eisenberg, P Rose, P Mitchell, P Young, J Matos, M Secord, A Davy, M Gargosky, S Gray, H |
| author_facet | Goh, J Mason, J Chan, J Moradi, M Berek, J Beningno, B Mileshkin, L Recio, F Tchabo, N Rossi, E Eisenberg, P Rose, P Mitchell, P Young, J Matos, M Secord, A Davy, M Gargosky, S Gray, H |
| author_sort | Goh, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991068 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39910682014-05-01 Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission Goh, J Mason, J Chan, J Moradi, M Berek, J Beningno, B Mileshkin, L Recio, F Tchabo, N Rossi, E Eisenberg, P Rose, P Mitchell, P Young, J Matos, M Secord, A Davy, M Gargosky, S Gray, H J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991068/ http://dx.doi.org/10.1186/2051-1426-1-S1-P213 Text en Copyright © 2013 Goh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Goh, J Mason, J Chan, J Moradi, M Berek, J Beningno, B Mileshkin, L Recio, F Tchabo, N Rossi, E Eisenberg, P Rose, P Mitchell, P Young, J Matos, M Secord, A Davy, M Gargosky, S Gray, H Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| title | Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| title_full | Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| title_fullStr | Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| title_full_unstemmed | Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| title_short | Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| title_sort | study of autologous dendritic cell therapy targeting mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991068/ http://dx.doi.org/10.1186/2051-1426-1-S1-P213 |
| work_keys_str_mv | AT gohj studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT masonj studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT chanj studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT moradim studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT berekj studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT beningnob studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT mileshkinl studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT reciof studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT tchabon studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT rossie studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT eisenbergp studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT rosep studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT mitchellp studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT youngj studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT matosm studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT secorda studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT davym studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT gargoskys studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission AT grayh studyofautologousdendriticcelltherapytargetingmucin1asatreatmentforthemaintenanceofovariancancerpatientsinremission |